<DOC>
	<DOC>NCT02176356</DOC>
	<brief_summary>A study to evaluate patient satisfaction, aesthetic and psychological impact of combined treatment with BOTOX® Cosmetic (onabotulinumtoxinA), JUVÉDERM® ULTRA XC, JUVÉDERM® ULTRA PLUS XC, JUVÉDERM® VOLUMA® XC, and LATISSE® (bimatoprost ophthalmic solution).</brief_summary>
	<brief_title>Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Qualified to receive treatment with BOTOX® Cosmetic, a facial filler (JUVÉDERM® ULTRA XC and/or JUVÉDERM® ULTRA Plus XC and/or JUVÉDERM® VOLUMA® XC) and LATISSE® treatment Naïve to botulinum toxin therapy of any serotype for any indication Naïve to prescription eyelash growth products of any type Naïve to dermal filler treatment in the face and neck Undergone facial plastic surgery, tissue grafting, tissue augmentation or facial dermal filler injections Had laser, photomodulation, intense pulsed light, radio frequency, dermabrasion or chemical peel in the face or neck Have received skin resurfacing (laser, photomodulation, intense pulsed light, radio frequency, dermabrasion, chemical peel, or nonablative procedures) in the face or neck within 3 months Systemic retinoid therapy within 1 year prior to study enrollment Presence of inflammation at the proposed injection site(s) Profound atrophy/excessive weakness of muscles in target areas of injection Known immunization or hypersensitivity to any botulinum toxin serotype Undergone oral surgery or dental procedures within 30 days No visible eyelashes Use of permanent eyeliner, eyelash implants, semipermanent eyelash tint, dye or extension Use of prescription eyelash growth products Unwilling or unable to remove contact lenses prior to study medication application in the evening and keep lenses out for 30 minutes Diagnosis of myasthenia gravis, EatonLambert Syndrome, amyotrophic lateral sclerosis, or any other disease that might interfere with neuromuscular function.</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>